Optimal dosage of cyclopentolate 1% for complete cycloplegia: A randomized clinical trial

European Journal of Ophthalmology

Volumn 17, Issue 3, 2007, Pages 294-300

  Bagheri, Abbas ^a   Givrad, S ^a   Yazdani, S ^a   Reza Mohebbi, M ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Autorefraction; Cyclopentolate; Cycloplegics; Refraction

Indexed keywords

CYCLOPENTOLATE; EYE DROPS; MYDRIATIC AGENT;

ACCOMMODATION PARALYSIS; ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; FLUSHING; HEART PALPITATION; HUMAN; HYPERMETROPIA; MALE; MYOPIA; NAUSEA; OPTIMAL DRUG DOSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REFRACTION ERROR; SIDE EFFECT; STRABISMUS; VOMITING; DRUG EFFECT; EYE REFRACTION; PRESCHOOL CHILD; PROSPECTIVE STUDY; PUPIL;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CYCLOPENTOLATE; FEMALE; HUMANS; MALE; MYDRIATICS; OPHTHALMIC SOLUTIONS; PROSPECTIVE STUDIES; PUPIL; REFRACTION, OCULAR; REFRACTIVE ERRORS; STRABISMUS;

EID: 34447118196     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210701700303     Document Type: Article

References (25)

1. Liesgang TJ, Deutsch TA, Grand MG. Optics, refraction and contact lenses in basic and clinical science course. Found Am Acad Ophthalmol 2004-2005; Sec 3: 142-4.
2. Caloroso EE, Rouse MW, Cotter SA. Clinical Management of Strabismus. Boston: Butterworth-Heinemann, 1993; 14-7.
3. Dollery C. Therapeutic Drugs. 2nd ed. New York: Churchill Livingstone, 1999; section A; 40-4.
4. Peyman GA, Saunders DR, Goldberg MF. Principles and Practice of Ophthalmology. Philadelphia: WB Saunders, 1980; 201-4.
5. Khurana AK, Ahluwalia BK, Raja C. Status of cyclopentolate as a cycloplegic in children: a comparison with atropine and homatropine. Acta Ophthalmol 1988; 66: 721-4.
6. Celebi S, Aykan U. Comparison of cyclopentolate and atropine in patients with refractive accommodative esotropia by means of retinoscopy, autorefractometry and biometric lens thickness. Acta Ophthalmol 1999; 77: 426-9.
7. Havener WH. Ocular Pharmacology. 5th ed. St. Louis: Mosby, 1978; 253-7.
8. Apt L. Pharmacology. In: Isenberg SJ, ed. The Eye in Infancy. 2nd ed. St. Louis: Mosby; 1994: 88-91.
9. Repka MX. Refraction in infants and children. In: Nelson LB, ed. Harley's Pediatric Ophthalmology. 4th ed. Philadelphia: WB Saunders, 1998; 117-8.
10. Vitale A, Foster CS. Mydriatic and cycloplegic agents. In: Zimmerman TJ, Kooner K, Sharir M, Fechtner R. Textbook of Ocular Pharmacology. Philadelphia: Lippincott Williams & Wilkins, 1997; 703-11.
11. Wong CY, Fan DSP, Yu CBO, Lam DSC. Topical mydriatic and cycloplegic spray for Chinese children. J Pediatr Ophthalmol Strabismus 2003; 40: 349-52.
12. Phelps CD. Examination and functional evaluation of crystalline lens. In: Tasman W, Jaeger EA, eds. Duane's Clinical Ophthalmology. Philadelphia: JB Lippincott, 1991; 1-23.
13. Ingram RM, Barr A. Refraction of 1-year-old children after cycloplegia with 1 % cyclopentolate; comparison with finding after atropinisation. Br J Ophthalmol 1979; 63: 348-52.
14. Rosenbaum AL, Bronwyn Bateman J, Bremer DL, Liu PY. Cycloplegic refraction in esotropic children, cyclopentolate versus atropine. Ophthalmology 1981; 88: 1031-4.
15. Goldenstein JH, Schneekloth BB. Atropine versus cyclopentolate plus tropicamide in esodeviations. Ophthalmic Surg Lasers 1996; 27: 1030-4.
16. Fraunfelder FT. Drug-Induced Ocular Side Effects and Drug Interactions. 2nd ed. Philadelphia: Lea and Febiger; 1982: 373-4.
17. Miranda MN, Sanjuan PR. Residual accommodation. A comparison between cyclopentolate 1% and a combination of cyclopentolate 1% and tropicamide 1%. Arch Ophthalmol 1972; 87: 515-7.
18. Nishizawa AR, Orton RB, Cadera W. Comparison of 0.5% cyclopentolate plus 0.5% tropicamide and 1% cyclopentolate alone for mydriasis of dark irides. Can J Ophthalmol 1988; 23: 299-300.
19. Khoo BK, Koh A, Cheong P, Ho NK. Combination of cyclopentolate and phenylephrine for mydriasis in premature infants with heavily pigmented irides. J Pediatr Ophthalmol Strabismus 2000; 37: 15-20.
20. Weiner N. Atropine, scopolamine and related antimus-carinic drugs. In: Goodman Gilman A, Goodman LS, Rall TW, Murad F. Goodman and Gilman's the Pharmacological Basis of Therapeutics. 7th ed. New York: Macmillan Publishing; 1985: 139-40.
21. Robb RM, Petersen RA. Cycloplegic refraction in children. J Pediatric Ophthalmol Strabismus 1968; 5: 110-4.
22. Parfitt K. Martindale, the Complete Drug Reference. 32nd ed. Massachusetts: Pharmaceutical Press; 1999: 455-9.
23. Salvasen S, Kohler M. Precision in automated refraction. Acta Ophthalmol 1991; 69: 338-41.
24. Salvasen S, Kohler M. Automated refractions, a comparative study of automated refraction with the Nidek AR-1000 autorefractor and retinoscopy. Acta Ophthalmol 1991; 69: 342-6.
25. Good WV, Hoyt CS. Strabismus Management. Boston: Butterworth-Heinemann, 1996; 284-5.